Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fearon, Abbie E."'
Autor:
Fearon, Abbie E., Slabber, Coenraad F., Kuklin, Andrii, Bachofner, Marc, Tortola, Luigi, Pohlmeier, Lea, Pantasis, Sophia, Hornemann, Thorsten, Chen, Lin, Kopf, Manfred, Werner, Sabine
Publikováno v:
In iScience 22 October 2021 24(10)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Slabber, Coenraad F., Bachofner, Marc, Speicher, Tobias, Kuklin, Andrii, Fearon, Abbie E., Padrissa-Altés, Susagna, Bogorad, Roman, Horváth Rudigier, Carla, Wüst, Daria, Krautbauer, Sabrina, Höring, Marcus, Liebisch, Gerhard, Anderson, Daniel G., Wolfrum, Christian, auf dem Keller, Ulrich, Werner, Sabine
Publikováno v:
Science Signaling, 16 (787)
Fibroblast growth factors (FGFs) are key regulators of the remarkable regenerative capacity of the liver. Mice lacking FGF receptors 1 and 2 (Fgfr1 and Fgfr2) in hepatocytes are hypersensitive to cytotoxic injury during liver regeneration. Using thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______150::3ae0bb849d2fd9ae0e2ffbdb0ae9a3e7
https://hdl.handle.net/20.500.11850/615776
https://hdl.handle.net/20.500.11850/615776
Autor:
Fearon, Abbie E., Carter, Edward P., Clayton, Natasha S., Wilkes, Edmund H., Baker, Ann-Marie, Kapitonova, Ekaterina, Bakhouche, Bakhouche A., Tanner, Yasmine, Wang, Jun, Gadaleta, Emanuela, Chelala, Claude, Moore, Kate M., Marshall, John F., Chupin, Juliette, Schmid, Peter, Jones, J. Louise, Lockley, Michelle, Cutillas, Pedro R., Grose, Richard P.
Publikováno v:
Fearon, A E, Carter, E P, Clayton, N S, Wilkes, E H, Baker, A-M, Kapitonova, E, Bakhouche, B A, Tanner, Y, Wang, J, Gadaleta, E, Chelala, C, Moore, K M, Marshall, J F, Chupin, J, Schmid, P, Jones, J L, Lockley, M, Cutillas, P R & Grose, R P 2018, ' PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer ', Cell Reports, vol. 22, no. 9, pp. 2469-2481 . https://doi.org/10.1016/j.celrep.2018.02.028
Cell Reports, Vol 22, Iss 9, Pp 2469-2481 (2018)
Cell Reports
Cell Reports, Vol 22, Iss 9, Pp 2469-2481 (2018)
Cell Reports
Summary Development of resistance causes failure of drugs targeting receptor tyrosine kinase (RTK) networks and represents a critical challenge for precision medicine. Here, we show that PHLDA1 downregulation is critical to acquisition and maintenanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::602f33c2ccf3b0af567f23e6b4e3388b
https://research-information.bris.ac.uk/en/publications/6eb0aafb-94f6-43b6-86ba-8c87b7463b00
https://research-information.bris.ac.uk/en/publications/6eb0aafb-94f6-43b6-86ba-8c87b7463b00
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Receptor Tyrosine Kinases: Family & Subfamilies; 2015, p265-295, 31p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fearon, Abbie E1, Grose, Richard P1
Publikováno v:
Nature Structural & Molecular Biology. Feb2014, Vol. 21 Issue 2, p113-114. 2p.
Autor:
Fearon AE; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Carter EP; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Clayton NS; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Wilkes EH; Integrative Cell Signalling and Proteomics, Centre for Haemato-Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Baker AM; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Kapitonova E; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Bakhouche BA; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Tanner Y; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Wang J; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Gadaleta E; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Moore KM; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Marshall JF; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Chupin J; Centre for Experimental Cancer Medicine, Barts Cancer Institute, London EC1M 6BQ, UK., Schmid P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, London EC1M 6BQ, UK., Jones JL; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Lockley M; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Cutillas PR; Integrative Cell Signalling and Proteomics, Centre for Haemato-Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Grose RP; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK. Electronic address: r.p.grose@qmul.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2018 Feb 27; Vol. 22 (9), pp. 2469-2481.